Stay updated on QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page’s revision tag was updated from v3.6.2 to v3.6.3, indicating a minor backend update rather than a user-facing content change.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page’s revision tag changed from v3.6.0 to v3.6.2, signaling a software update to the page. It likely includes bug fixes or UI improvements without altering the study content or data shown.SummaryDifference0.0%

- Check34 days agoChange DetectedRecruitment status updated to closed ('No longer looking for participants'), indicating no enrollment at this time. New user-focused sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added to help visitors understand and participate, along with a minor formatting change to the Intervention/Treatment label and a revision note (Revision: v3.6.0).SummaryDifference0.3%

- Check41 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a deployment or minor update to the site rather than a change to study content.SummaryDifference0.0%

- Check62 days agoChange DetectedA new revision label v3.5.4 has been added, replacing the previous v3.5.3. This appears to be an update to the page’s release notes or documentation rather than substantive changes to study data or content.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page header/footer software revision was updated from v3.5.2 to v3.5.3, reflecting a ClinicalTrials.gov site release rather than modifying the study record details.SummaryDifference0.0%

Stay in the know with updates to QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.